OnabotulinumtoxinA for the Treatment of Chronic Migraine: Long-Term Outcome

被引：0
|
作者：
Rothrock, J. F. [1 ]
Andress-Rothrock, D. [1 ]
Scanlon, C. [1 ]
Weibelt, S. [1 ]
机构：
[1] Univ Alabama, Dept Neurol, Sch Med, Birmingham, AL 35294 USA
来源：
HEADACHE | 2011年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
    Navarro-Perez, Maria Pilar
    Gonzalez-Quintanilla, Vicente
    Munoz-Vendrell, Albert
    Madrigal, Elisabet
    Alpuente, Alicia
    Latorre, German
    Molina, Francis
    Monzon, Maria Jose
    Medrano, Vicente
    Garcia-Azorin, David
    Gonzalez-Oria, Carmen
    Gago-Veiga, Ana
    Velasco, Fernando
    Beltran, Isabel
    Morollon, Noemi
    Viguera, Javier
    Casas-Limon, Javier
    Rodriguez-Vico, Jaime
    Cuadrado, Elisa
    Irimia, Pablo
    Iglesias, Fernando
    Guerrero-Peral, angel Luis
    Belvis, Robert
    Pozo-Rosich, Patricia
    Pascual, Julio
    Santos-Lasaosa, Sonia
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [22] OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort
    Francesca Schiano di Cola
    Elisa Pari
    Salvatore Caratozzolo
    Chiara Mancinelli
    Paolo Liberini
    Renata Rao
    Alessandro Padovani
    Neurological Sciences, 2018, 39 : 159 - 160
  • [23] P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
    Simona Guerzoni
    Maria Michela Cainazzo
    Luigi Alberto Pini
    The Journal of Headache and Pain, 2015, 16
  • [24] Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
    Katja Kollewe
    Claus M. Escher
    Dirk U. Wulff
    Davood Fathi
    Lejla Paracka
    Bahram Mohammadi
    Matthias Karst
    Dirk Dressler
    Journal of Neural Transmission, 2016, 123 : 533 - 540
  • [25] Long-term outcome of migraine
    Granella, F
    Cavallini, A
    Sandrini, G
    Manzoni, GC
    Nappi, G
    CEPHALALGIA, 1998, 18 : 30 - 33
  • [26] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Blumenfeld, Andrew M.
    Stark, Richard J.
    Freeman, Marshall C.
    Orejudos, Amelia
    Adams, Aubrey Manack
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [27] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Andrew M. Blumenfeld
    Richard J. Stark
    Marshall C. Freeman
    Amelia Orejudos
    Aubrey Manack Adams
    The Journal of Headache and Pain, 2018, 19
  • [28] Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
    Kollewe, Katja
    Escher, Claus M.
    Wulff, Dirk U.
    Fathi, Davood
    Paracka, Lejla
    Mohammadi, Bahram
    Karst, Matthias
    Dressler, Dirk
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (05) : 533 - 540
  • [29] OnabotulinumtoxinA for the Treatment of Chronic Migraine
    Rothrock, John F.
    HEADACHE, 2011, 51 (04): : 659 - 660
  • [30] OnabotulinumtoxinA for Treatment of Chronic Migraine
    Markert, Ronald J.
    Solomon, Glen D.
    HEADACHE, 2011, 51 (06): : 1002 - 1003
12345